Strides Pharma stock slips after USFDA observations for Bangalore plant – Indiainfoline


Strides Pharma stock slips after USFDA observations for Bangalore plant
Indiainfoline
Strides Pharma stock slips after USFDA observations for Bangalore plant. The US authority has issued a Form 483 after completion of pre-approval product inspection on August 25, the company said. September 18, 2018 23:44 IST | India Infoline News …



Read the full Bangalore News here

Some local news is curated - Original might have been posted at a different date/ time! Click the source link for details.

Leave a Reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.